Group structure

Through Hutchison MediPharma, Chi-Med researches and develops TCM-derived botanical, semi-synthetic natural product drugs and small molecule drugs for the global market. We focus on the oncology and auto-immune therapeutic areas.

Chi-Med has three operating joint ventures in the fast growing China TCM market: Hutchison Baiyunshan; Shanghai Hutchison Pharmaceuticals; and Hutchison Healthcare. These joint ventures are increasingly strong cash generators from the development, manufacture and marketing of both prescription and over-the-counter TCM pharmaceuticals and health supplements. Chi-Med plans to establish further joint ventures in the future.

Chi-Med is developing "Sen" as a quality TCM consumer brand in TCM medicines and treatments, food & beverage, and skin and body care products through its own network of retail stores and third party luxury goods retailers.